Search

Search Constraints

You searched for: Author/Creator Rubio, Isabel T

Search Results

1. 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age. Issue 4 (April 2021)

2. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. Issue 12 (30th October 2018)

3. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. Issue 12 (30th October 2018)

4. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. Issue 12 (30th October 2018)

5. Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox. Issue 1 (January 2021)

7. European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission. Issue 1 (January 2023)